*Department of Epidemiology and Injury Prevention Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
†Department of Preventive Medicine and Public Health, University of Kansas Medical Center, Kansas City, KS
‡Duke Clinical Research Institute, Durham, NC
This research was supported by Cooperative Agreement U01 CE002160-01 from the National Center for Injury Prevention and Control at the Centers for Disease Control and Prevention (NCIPC/CDC) and award R49-CE001495 to the University of North Carolina for an Injury Control Research Center from NCIPC/CDC.
R.B.N. received fellowship support from the University of North Carolina’s Royster Society of Fellows. A.W.R. receives support from a CTSA grant from the National Center for Advancing Translational Sciences at the National Institutes of Health awarded to the University of Kansas Medical Center for Frontiers: The Heartland Institute for Clinical and Translational Research (KL2TR000119).
Initial findings were presented as an abstract at the National Rx Drug Abuse & Heroin Summit, April 2018, Atlanta, GA.
The authors declare no conflict of interest.
Reprints: Rebecca B. Naumann, PhD, Injury Prevention Research Center, University of North Carolina at Chapel Hill, CVS Plaza, Suite 500, 137 East Franklin Street, CB#7505, Chapel Hill, NC 27599. E-mail: [email protected]
